Cell MedX gets BCSC cease trade order, grants security over eBalance IP on ~$539k loan

Stimcell Energetics Inc.

BCSC issued cease trade order on Oct 11, 2022 for failing to file annual financial statements due to insufficient audit funds.
Consolidated ~$539,325 in loans from major shareholder Richard Jeffs; granted security interest over eBalance Technology and IP on default.
Loans remain due on demand with 6% annual interest compounded monthly; no revenue from eBalance Systems yet.
Company cannot assure it will raise necessary funding to remedy filing defaults or complete the audit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.